Dermapharm Holding SE (DMP) - Total Liabilities

Latest as of December 2025: €1.49 Billion EUR ≈ $1.74 Billion USD

Based on the latest financial reports, Dermapharm Holding SE (DMP) has total liabilities worth €1.49 Billion EUR (≈ $1.74 Billion USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore Dermapharm Holding SE (DMP) cash conversion ratio to assess how effectively this company generates cash.

Dermapharm Holding SE - Total Liabilities Trend (2013–2025)

This chart illustrates how Dermapharm Holding SE's total liabilities have evolved over time, based on quarterly financial data. Check Dermapharm Holding SE (DMP) asset resilience to evaluate the company's liquid asset resilience ratio.

Dermapharm Holding SE Competitors by Total Liabilities

The table below lists competitors of Dermapharm Holding SE ranked by their total liabilities.

Company	Country	Total Liabilities
Central Puerto S.A. BA:CEPU	Argentina	AR$1.05 Trillion
Knowles Cor NYSE:KN	USA	$275.30 Million
Sichuan Swellfun Co Ltd SHG:600779	China	CN¥3.25 Billion
Jiaozuo Wanfang Aluminum SHE:000612	China	CN¥1.14 Billion
Inv La Constru SN:ILC	Chile	CL$16.08 Trillion
Piramal Pharma Limited NSE:PPLPHARMA	India	Rs81.16 Billion
Santam JSE:SNT	South Africa	ZAC65.81 Billion
Bayer Cropscience Limited NSE:BAYERCROP	India	Rs20.68 Billion

Liability Composition Analysis (2013–2025)

This chart breaks down Dermapharm Holding SE's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see market cap of Dermapharm Holding SE.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	2.05	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	2.15	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.68	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Dermapharm Holding SE's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Dermapharm Holding SE (2013–2025)

The table below shows the annual total liabilities of Dermapharm Holding SE from 2013 to 2025.

Year	Total Liabilities	Change
2025-12-31	€1.49 Billion ≈ $1.74 Billion	+1.41%
2024-12-31	€1.47 Billion ≈ $1.72 Billion	-8.91%
2023-12-31	€1.62 Billion ≈ $1.89 Billion	+83.52%
2022-12-31	€880.34 Million ≈ $1.03 Billion	-2.95%
2021-12-31	€907.13 Million ≈ $1.06 Billion	+0.81%
2020-12-31	€899.81 Million ≈ $1.05 Billion	+18.34%
2019-12-31	€760.38 Million ≈ $888.97 Million	+69.54%
2018-12-31	€448.50 Million ≈ $524.34 Million	+31.29%
2017-12-31	€341.62 Million ≈ $399.39 Million	+36.16%
2016-12-31	€250.89 Million ≈ $293.32 Million	-0.53%
2015-12-31	€252.22 Million ≈ $294.88 Million	-14.96%
2014-12-31	€296.59 Million ≈ $346.74 Million	-3.90%
2013-12-31	€308.62 Million ≈ $360.80 Million	--

About Dermapharm Holding SE

XETRA:DMP Germany Drug Manufacturers - Specialty & Generic

Market Cap

$2.92 Billion

€2.50 Billion EUR

Market Cap Rank

#5721 Global

#882 in Germany

Share Price

€46.35

Change (1 day)

+0.65%

52-Week Range

€32.05 - €47.25

All Time High

€80.48